 The findings from this study will allow the authors to better elucidate the role of liposomal bupivacaine in expanderimplant based breast reconstruction. In doing so, they may allow the authors to identify the ideal pain regimen for these patients. This holds important implications, with the potential to reduce postoperative pain, opioid consumption, opioid related adverse events, length of stay, and patient satisfaction. 